INSIDER TRADING

Replimune Group, Inc. chief medical officer Konstantinos Xynos sells $349,877 of REPL shares

By Insider Stock Trader Newsroom, Insider Stock Trader: Alerts app2 min readInsider Stock Trader
Replimune Group, Inc. chief medical officer Konstantinos Xynos sells $349,877 of REPL shares

After the sale, the filing lists 208,017 shares held. By the Insider Stock Trader: Alerts app. Information only, not investment advice.

A chief medical officer at Replimune Group, Inc., Konstantinos Xynos, sold 16,198 shares of the company's stock on the open market on Nov 16. The sale, at an average of $21.60 a share, comes to $349,877.

The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. Six Replimune Group, Inc. insiders sold on the open market within 14 days, a pattern known as a cluster sell.

The trade was reported within two business days, as Section 16 requires. After the trade, the filing lists 208,017 shares held.

Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.

The sale
CompanyReplimune Group, Inc. (REPL)
InsiderKonstantinos Xynos
RoleChief Medical Officer
TransactionOpen-market sale (code S)
Shares16,198
Average price$21.60
Value$349,877
Trade dateNov 16, 2026
Filed with the SECNov 18, 2026, 7:32 PM ET
Shares held after208,017
OwnershipDirect
Rule 10b5-1 planNot marked in the filing

See this filing row by row in Insider Stock Trader

View the Form 4 on SEC.gov

Follow REPL for the next insider trade · See where several insiders traded together

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.